Poster Presentations: 9th International Calicivirus Conference

Entry and Replication

Abstract Title	Presenter
Comparison of Human Intestinal Enteroids and Zebrafish Larvae for GI and GII Human Norovirus Replication	Kristen Gibson, University of Arkansas, Fayetteville
Comparison of human norovirus replication in two zebrafish systems: embryos and larvae	Charlène Plénière, Université Laval
Cross-Species Profiling of MNV Protease Cleavage Events Using Quantitative Proteomics	Frazer Buchanan, University of Liverpool
Dissecting the Mechanism of Glycocholic Acid–Mediated Enhancement of Human Sapovirus Infection in Caco-2 MC Cells	Miyabi Arai, Kitasato University
Engineering customized receptors to culture human norovirus	Robin Veenstra, Utrecht University
Establishment of a novel Caco-2-based cell culture system for human sapovirus propagation	Reiko Todaka, Kitasato University
Evaluation of novel in vitro models for human sapovirus infection	Magdalena Neijd, Linköping University, Sweden
Evaluation of the replication efficiency of human noroviruses in salivary gland cells	Neda Nasheri, Health Canada (HC)
Higher polymerase activity associated with epidemic potential of norovirus strains	Miranda de Graaf, Erasmus MC
Infectious cDNA Clone of Human Norovirus GII.4 Sydney: A Comparative Analysis with Murine Norovirus	Marit Lingemann, Heidelberg University
Norovirus cleavage of hnRNP-K enhances virus replication	Vernon Ward, University of Otago
Novel Use of Porcine Gastric Mucin-Coated Beads to Enrich Infectious Human Norovirus Prior to Infection of Human Intestinal Enteroids	Samantha Wales, FDA
Regulation of Cardiolipin Externalization in the context of Noroviral Infection	Maham Saeed, UT SOUTHWESTERN MEDICAL CENTER
Strain-Specific Functional Diversity in GII.4 Norovirus Entry: HBGA-Dependent Capsid Clustering and Membrane Remodeling	B.Vijayalakshmi Ayyar, Baylor College of Medicine
Surface Glycans as Therapeutic Targets to Prevent Human Norovirus and Rotavirus Infections in a Human Intestinal Enteroid Model	Stefan Taube, University of Lübeck
The stress granule protein G3BP1 mediates norovirus VPg-dependent translation through eIF4GI-mediated interactions	Liliana Echavarria-Consuegra, University of Cambridge
Unexpected roles for lipids in promoting murine norovirus binding and entry	Robert Orchard, University of Texas Southwestern Medical Center
Zebrafish Larvae Support Long-term Passaging of Human Norovirus	Lorane Molineaux, KU Leuven

Structure and Pathogenesis

Abstract Title	Presenter
Evaluating GII.4 human norovirus infection in enteroendocrine cells using human intestinal enteroids	Hephzibah Nwanosike, Baylor College of Medicine
High Levels of Co-detection of Norovirus and Other Enteric Co-Pathogens in Hospitalized Patients With and Without Acute Gastroenteritis in Bangladesh	Farzana Fariha, International Center for Diarrheal Disease Research, Bangladesh
Macrophage phagocytosis of HuNoV infected cells in an ex vivo human enteroid-macrophage co-culture model	Ngan Fung Li, Baylor College of Medicine
Pandemic GII.4/Sydney VLP exhibits decreased conformational flexibility compared to a GII.4 consensus VLP vaccine candidate	Ramakrishnan Anish, Baylor College of Medicine
pH and Bile Acid Differentially Regulate Human Norovirus GII.3 Capsid Dynamics	Carmen Apostol, Baylor College of Medicine
Small Fish, Big Insights: A Zebrafish Tale of Tulane Virus Tropism	Sahaana Chandran, University of Arkansas, Fayetteville
Synergistic Effect of Magnesium and Bile Acid GCDCA on Antibody Escape by Human Norovirus	Stefan Taube, University of Lübeck

Interaction between Calicivirus and host microbiota

Epidemology

Abstract Title	Presenter
Comparing Norovirus Gastroenteritis in Medically-Attended Patients and Community-Cohort in Central Wisconsin, United States	Joshua Petrie, Marshfield Clinic Research Institute
Detection of caliciviruses in older children, adults and the elderly in selected sentinel sites in South Africa, 2018-2024	Nicola Page, National Institute for Communicable Diseases
Epidemiology of norovirus infections and acute gastro-enteritis in adults 65 yrs and older in peri-urban Lima, Peru.	Claudio F Lanata, Instituto de Investigación Nutricional
Health care costs associated with norovirus in adults, Veterans Health Administration 2010 – 2024	Jordan Cates, Centers for Disease Control and Prevention
Impact of the SARS-CoV-2 Pandemic on Medically Attended Acute Gastroenteritis Incidence and Health Care Utilization in the U.S.	Mark Schmidt, Kaiser Permanente Center for Health Research
Machine learning methods improve norovirus outbreak forecasting in the United States	Sara Kim, Emory University
Molecular Epidemiology of Noroviruses In Mexico: Challenges and Inclusion in Global Surveillance-The Role of NoroSurv.	Fabian Gomez, Instituto de Diagnóstico y Referencia Epidemiológicos
Molecular surveillance for norovirus among children under 5 years of age with medically-attended acute gastroenteritis in Costa Rica, 2021-April 2025	Mariel López, Inciensa
Norovirus epidemiology in Alberta, Canada during July 2022 to March 2025	Kanti Pabbaraju, Alberta Precision Labs
Norovirus GII.17 Surpasses GII.4 Outbreaks in the United States	Leslie Barclay, Centers for Disease Control and Prevention
Norovirus in acute gastro-enteritis in children	Claudio F Lanata, Instituto de Investigación Nutricional
Oyster-associated norovirus outbreaks in the United States, January 2009—December 2024	Anita K. Kambhampati, Centers for Disease Control and Prevention
Patterns of coinfection with enteric pathogens in norovirus infections	leidy altamirano, Universidad de Antofagasta
Perceived Health Status among Patients with Norovirus and Acute Gastroenteritis	Holly Groom, Kaiser Permanente Center for Health Research
Symptom status and severity of norovirus infections among a cohort of young US children	Jennifer L. Cannon, CDC Foundation
The Prevalence of Human Sapovirus in Alberta, Canada from 2018-2024	Judy Qiu, Alberta Public Health Laboratory/University of Alberta

Advances in diagnostics and detection

Abstract Title	Presenter
Advanced Techniques in Calicivirus Detection and Genotyping Through DNA Hybridisation Enrichment Combined with Nanopore Sequencing	Lucas Jollie, University of Amsterdam
A Modified Next-Generation Sequencing Methodology for Norovirus Genotyping	Adam Bissonnette, Marshfield Clinic Research Institute
In Silico Characterization of VNAR–VP1 Interactions for Potential Norovirus Detection and Immunotherapy	Richard Olivares, Universidad de Antofagasta

Molecular Epidemiology & Evolution

Abstract Title	Presenter
Emergence and Molecular Epidemiology of a New Norovirus GII.17[P17] Variant in Thailand, 2024	Watchaporn Chuchaona, Chulalongkorn University
Emergence of norovirus GII.17[P16] during the COVID-19 outbreak in Thailand, 2021−2023	Leera Kittigul, Department of Microbiology, Faculty of Public Health, Mahidol University, Bangkok, Thailand
Genotypes and Clinical Manifestations of Sapovirus-Associated Gastroenteritis in Mie Prefecture, Japan, 2010–2022	Tomoichiro OKA, National Institute of Health Sciences
Metagenomic Analysis of Enteropathogenic Diversity Using Next-Generation Sequencing in Norovirus-Positive Stool Samples from Children Under 3 Years of Age Hospitalized With Acute Gastroenteritis at Dr. Luis Calvo Mackenna Hospital, Santiago, Chile	Carlos Garrido, University of Antofagasta
Metaviromics reveals a diversity of viruses belonging to the Caliciviridae family in seal feces.	Marion Desdouits, Ifremer
Molecular Characterization of Noroviruses Causing Acute Gastroenteritis in Vietnam from 2016 to 2021 and the Detection of GII.4 Hong Kong Variant	Ly Le, National Institute of Hygiene and Epidemiology
Molecular Epidemiology of Norovirus among Children less than 5 years of age in the Philippines, 2016-2023	(not set)
Molecular genetic characterization of the GII.17 norovirus strains in South Korea	Myung-Guk Han, KDCA
Norovirus gastroenteritis severity is associated with secretor status in young children from Vhembe District, South Africa.	Jean-Pierre KABUE, University of Venda
Norovirus genotypes circulating in South African children with gastroenteritis between 2023 and 2025	Janet Mans, University of Pretoria
Norovirus Genotypes in Community and Hospital Settings in Bangladesh	Muhammad Talha, icddr,b
Prediction of Serotypes by Molecular Phylogenetic Analysis of Enteric Infectious Viruses	Kana Kidera, Laboratory of Viral Infection Control, Ōmura Satoshi Memorial Institute, Graduate School of Infection Control Sciences, Kitasato University
Prevalence of GII.4 and GII.17 genotypes in the population of the state of Maranhão, Amazon region in Brazil and whole genome sequencing of GII.17 genotypes.	Yan Pimenta, Oswaldo Cruz Institute
Trends in Enteric Virus Infections Among Children Under Five in South Korea, 2020-2024	Sun-Whan Park, KDCA
Updated classification and nomenclature of GII.4 and GII.17 norovirus variants	Preeti Chhabra, Centers for Disease Control and Prevention

Vaccines and immunity

Abstract Title	Presenter
Atomic resolution structures of neutralizing antibodies bound to immunodominant epitopes provides new insights into GII.4 norovirus immune evasion	Anisa Ghosh, University of California,Santa Cruz
Characterization of intestinal mucosal immunity in Nicaraguan children with sapovirus acute gastroenteritis	Sylvia Becker-Dreps, University of North Carolina at Chapel Hill
Complex Genetic Traits Regulate the Kinetics, Magnitude and Durability of Norovirus mRNA LNP Vaccine Performance in Outbred Populations.	Ralph Baric, UNC Chapel Hill
Estimates of the Public Health Impact of Norovirus Vaccination for Older Adults in the United States	Brandon Patterson, Moderna, Inc.
Estimating the potential population-level impact of a norovirus vaccine that reduces symptoms and viral shedding among breakthrough infections using mathematical modeling	Maria Garcia Quesada, Emory University
Maternal humoral immunity and protection against norovirus GII gastroenteritis in a birth cohort	Sylvia Becker-Dreps, University of North Carolina at Chapel Hill
Optimization and miniaturization of a Human Intestinal Enteroid (HIE) neutralization assay for evaluating homotypic human norovirus (HuNoV) antibody responses	KHALIL ETTAYEBI, BAYLOR COLLEGE OF MEDICINE
Qualitative trait loci mapping identifies host alleles that influence norovirus mRNA LNP vaccine neutralizing antibody responses.	Ralph Baric, University of North Carolina Chapel Hill
Safety, Tolerability, and Immunogenicity of an oral adenovirus-vectored GI.1/GII.4 norovirus vaccine in breastfeeding women: a phase 1, double-blind, randomized placebo-controlled clinical trial	James Cummings, VAXART

Food & Environmental Virology-I (Food)

Abstract Title	Presenter
Aerosol deposition of HuNoV models on surfaces and food	Linda SANKA, Université Laval
Comparative Evaluation of Human Norovirus Inactivation by Sodium Hypochlorite Using Zebrafish Embryos and iPSC-derived Human Intestinal Organoids	Changsun Choi, Chung-Ang University
Evaluating Stability of Tulane Virus, a Human Norovirus Surrogate, and an Indicator of Human Fecal Contamination on Fresh Strawberries	Cameron Boerner, Food and Drug Administration
Evaluation of an automated ultrafiltration system as a concentration method for recovery of infectious norovirus from berries	Efstathia (Efi) Papafragkou, US Food and Drug Administration
Evaluation of heat inactivation of human norovirus using two distinct cultivation systems	Kosuke Murakami, Japan Institute for Health Security
Evaluation of sensitivity and heat susceptibility of isolated human Sapovirus in the HuTu80 cells culture model.	Philippe Raymond, Canadian Food Inspection Agency
Feeding- and temperature-dependent accumulation of norovirus like particles in oysters	Ayaka Takahashi-Okino, Japan Institute for Health Security
Impact of Soilless Substrate Type on Tulane Virus Persistence and Localization during Recirculating Deep Water Culture Hydroponic Cultivation of Leaf Lettuce	Kristen Gibson, University of Arkansas System Division of AgricultureGayatri Dhulappanavar, University of Arkansas System Division of Agriculture
Inactivation of feline calicivirus by a 255 nm ultraviolet light emitting diode system	Doris D'Souza, University of TennesseeElena Jerkovic, University of TennesseeBrahmaiah Pendyala, Tennessee State UniversityAnkit Patras, Tennessee State University
Long-Term Survival of Murine Norovirus, Simian Rotavirus, and Porcine Sapovirus in Drinking Water	Ziwei Zhao, University of Helsinki
Single Lab Validation of Dead-end Ultrafiltration for Isolation of Hepatitis A Virus and Human Norovirus in Agricultural Water and RT-qPCR Detection	Christine Yu, U.S. Food and Drug Administration
Virological analyses in collective catering outbreaks in France between 2018 and 2024	Catherine HENNECHART-COLLETTE, Anses, Laboratory for food safety, Maisons-Alfort, France

Food & Environmental Virology-II (Wastewater & others)

Abstract Title	Presenter
Hybrid Capture Genome Sequencing in Wastewater-Based Surveillance for Tracking Norovirus and Sapovirus in Alberta Communities	Linnet Immaraj, University of Alberta
Molecular Detection of Noroviruses in Environmental Wastewater in Lagos State, Nigeria	Olumuyiwa Babalola Salu, College of Medicine, University of Lagos
Murine Norovirus Inactivation and Adaptation to Ammonia	Putri Shafa Kamila, Tohoku University
Norovirus genetic diversity on watershed scale: interest of passive sampling	Soizick F. Le Guyader, IFREMER Institute
OCCURRENCE OF HUMAN NOROVIRUS, HEPATITIS E VIRUS AND SARS-COV-2 IN RIVER WATER (RIVER VANTAA) AND TREATED WASTEWATER, IN FINLAND	Leena Maunula, University of Helsinki

Prevention & Control (antivirals)

Abstract Title	Presenter
Broad-Spectrum Inhibition of Norovirus Protease Across Diverse Genotypes by Substrate-Mimetic Compounds	Ladislau Kovari, Wayne State University
BTP2 restricts Tulane virus and human norovirus replication independent of store-operated calcium entry	Joseph Hyser, Baylor College of Medicine
High throughput screening on murine norovirus to identify antiviral compounds	Johanna Becker, Center for Integrative Infectious Disease Research, Uni Heidelberg, Molecular Virology
Persistence and Disinfection profiles of Hypochlorite and Alcohols against Human Norovirus using Human Intestinal Enteroids	Geun Woo Park, Centers for Disease Control and Prevention
The Role of Human Intestinal Enteroids as a Platform to Assess Norovirus Prevention and Control Interventions	Verónica Costantini, Centers for Disease Control and Prevention